Pleiotropic effects of trimetazidine

Pleiotropic effects of trimetazidine

Aim. To investigate potential pleiotropic effects of trimetazidine (PreductalMB) in patients with stable effort angina. Material and methods. This randomised controlled clinical study included 95 patients with Functional Class I–III stable effort angina and Stage 2–3 arterial hypertension. Clinical...

Full description

Bibliographic Details
Main Authors:	O. V. Romashchenko, G. N. Klochkova, E. I. Mukhanova, I. V. Gaivoronskaya
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2013-08-01
Series:	Российский кардиологический журнал
Subjects:	coronary heart disease stable angina metabolism patients pleiotropic effects trimetazidine (preductal mb)
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/408

Similar Items

Cliniko-experimental research of trimetazidine efficiency at the myocardium ischemia
by: O. V Romashchenko
Published: (2013-06-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

Features of anti-ischemic efficacy of trimetazidine MR, assigned in combination with metoprolol in patients with angina
by: P. Yu Bardybakhin, et al.
Published: (2013-03-01)

TRIMETAZIDINE ADDITION TO ANTIANGINAL THERAPY: EFFECTS ON EFFICACY AND QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA TREATED OUTPATIENTLY
by: M A Shalenkova
Published: (2012-04-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Comparing effectiveness of adding prolonged trimetazidine or isosorbide dinitrate to beta-adrenoblocker therapy in stable angina patients
by: M. G. Glezer, et al.
Published: (2006-08-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

ACPTI study: Being positive in a negative situation is not naivety – Trimetazidine still has role in symptomatic CAD patients
by: Jamshed Dalal, et al.
Published: (2021-01-01)

Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure
by: Jamshed J. Dalal, et al.
Published: (2017-05-01)

Personalized trimetazidine prescription as a cytoprotective agent in patients with coronary artery disease
by: O. V. Romashchenko
Published: (2021-07-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)
by: N. M. Kolomoets, et al.
Published: (2009-12-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA
by: Maria G. Glezer, et al.
Published: (2020-05-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial
by: Maria G. Glezer, et al.
Published: (2019-02-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

New perspectives in optimizing treatment of coronary heart disease and arterial hypertension patients
by: N. A. Nikolaev
Published: (2008-02-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

Triple antianginal combinations in the treatment of elderly and senile patients with stable angina
by: S G Kanorskii, et al.
Published: (2016-12-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

Therapeutic possibilities of myocardial cytoprotector trimetazidine MR incoronary heart disease
by: D. I Trukhan
Published: (2014-12-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
by: Li QU, et al.
Published: (2018-06-01)

METABOLIC MYOCARDIAL CYTOPROTECTORS IN THERAPY OF STABLE ISCHEMIC HEART DISEASE: EVIDENCE OF EFFECTIVENESS AND USE RECOMMENDATIONS
by: N. B. Perepech
Published: (2017-11-01)

THERAPY OF STABLE ANGINA OF EFFORT BY TRIPLE COMBINATIONS OF ANTIANGINAL DRUGS IN GERIATRIC PRACTICE
by: S. G. Kanorsky, et al.
Published: (2017-11-01)